The suit alleges Pfizer knowingly distributed Quillivant XR, a drug used for treating attention-deficit/hyperactivity disorder, to children on Medicaid — despite the drug’s pattern of failing quality control tests.

Acting on behalf of the state of Texas, Attorney General Ken Paxton on Monday unsealed a lawsuit against Pfizer and its drug manufacturer, Tris Pharma, alleging the companies sold medication to children even though they knew the drug was ineffective and potentially unsafe.

The suit, filed in the Harrison County District Court, alleges Pfizer knowingly distributed a drug used for treating attention-deficit/hyperactivity disorder (ADHD) to children on Medicaid — despite the drug’s pattern of failing quality control tests.

The drug, Quillivant XR, is a stimulant that affects brain and nerve chemicals involved in hyperactivity and impulse control.

Posted in

Iron Will

Leave a Comment

You must be logged in to post a comment.